Kimbell Royalty Partners LP buy krebskrebs
Start price
21.09.20
/
50%
€5.58
Target price
04.11.21
€7.00
Performance (%)
124.00%
End price
05.11.21
€12.49
Summary
This prediction ended on 05.11.21 with a price of €12.49. With a performance of 124.00% the BUY prediction by krebskrebs was a big success. Dividends of €1.13 are taken into consideration when calculating the performance. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kimbell Royalty Partners LP | -0.348% | -0.348% | 3.350% | 79.894% |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% | 15.392% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% | 42.396% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% | 0.891% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% | 41.095% |
Comments by krebskrebs for this prediction
In the thread Kimbell Royalty Partners LP diskutieren
In the thread Trading Kimbell Royalty Partners LP
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten